Format

Send to

Choose Destination
Methods Mol Biol. 2013;986:325-37. doi: 10.1007/978-1-62703-311-4_20.

In vivo target validation by inducible RNAi in human xenograft mouse models.

Author information

1
Pharmacology Department of BU Oncology, Nerviano Medical Sciences, Nerviano, MI, Italy.

Abstract

Proper target selection and validation are crucial to the discovery of new anti-cancer agents. Since tumors depend on a suitable microenvironment for their growth, once a putative target has been identified, its validation should be performed whenever possible in vivo. This chapter deals with the generation of human xenograft mouse models genetically modified to induce the modulation of cancer-related genes as an approach to validate oncology targets.

PMID:
23436421
DOI:
10.1007/978-1-62703-311-4_20
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center